Senior insider sale
Chairman, President & CEO at INTRA-CELLULAR THERAPIES, INC. — senior position signals high conviction
$4.37M
51K shares
What this filing means
MATES SHARON plans to sell 51K shares of INTRA-CELLULAR THERAPIES, INC. valued at approximately $4.37M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/4/2024ACC: 0002002698-24-000525
DirectorOfficer· Chairman, President & CEO
Since Dec 2018
51K
Shares to sell
$4.37M
Approx. market value
172.70K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
compensation
compensation
1/8/2019
172.70KTotal acquired172.70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/8/2019 | compensation compensation | 172.70K | — |
| Total | 172.70K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
51K
Market value
$4.37M
12/4/2024
Total
Units
51K
Value
$4.37M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/4/2024 | 51K | $4.37M | NASDAQ | Planned |
| Total | 51K | $4.37M | ||